Saturday 17 October 2026
Export TDOC’s income statement to Excel — free account
Teladoc Health, Inc.
TDOC Healthcare Health Information Services
Teladoc Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, down 1.54% from fiscal 2024. In the quarter to June 2026, revenue fell 3.95%, EPS fell 10.5%, free cash flow fell 27.1% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
5.67
0.30
−5.03%
Follow TDOC
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 4 | 6 | 4 | 7 | 3 | 4 | 4 | 2 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(6.66) | (5.98) | (3.13) | (13.27) | 5.13 | 5.74 | 6.24 | 3.91 | 3.99 | 4.78 |
P/S ratio |
0.49 | 0.60 | 1.39 | 1.51 | 7.09 | 16.54 | 10.87 | 7.81 | 8.60 | 5.67 |
P/FCF ratio |
8.98 | 25.91 | 99.71 | 0.00 | 193.02 | 0.00 | 519.46 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(16.73) | (14.88) | (8.91) | (29.80) | 9.94 | 8.81 | 2.48 | 2.90 | 1.29 | 1.08 |
Beneish M-Score |
(3.26) | (4.38) | (3.08) | (18.63) | (2.26) | (0.85) | (2.59) | (2.18) | (2.14) | (2.11) |
P/Operating CF |
14.06 | 18.05 | 27.75 | 55.62 | 173.18 | (157.46) | 331.91 | 1,318.23 | (275.80) | (92.71) |
P/B ratio |
0.89 | 1.04 | 1.55 | 1.58 | 0.90 | 1.14 | 5.93 | 3.22 | 3.59 | 3.03 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 141.55 | 114.41 | 0.00 | 39.22 |
EV/Sales |
0.79 | 0.70 | 1.55 | 1.78 | 7.26 | 17.12 | 10.74 | 7.66 | 8.97 | 5.50 |
EV/EBITDA |
10.79 | 11.81 | 40.28 | 246.04 | 967.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
6.79 | 6.11 | 11.53 | 22.59 | 76.05 | (350.09) | 198.98 | (658.87) | (60.79) | (13.05) |
EV/FCF |
14.55 | 29.98 | 111.48 | (30.60) | 197.61 | (184.44) | 513.27 | (263.92) | (48.87) | (11.96) |
Quick Ratio |
2.41 | 1.61 | 3.19 | 2.82 | 3.22 | 2.87 | 6.37 | 8.36 | 3.70 | 3.78 |
Current Ratio |
2.77 | 1.77 | 3.54 | 3.29 | 3.70 | 3.19 | 6.52 | 8.53 | 3.87 | 3.93 |
Net Debt/EBITDA |
1.15 | 1.60 | 4.14 | 36.31 | 22.48 | (1.66) | 7.13 | 4.05 | (2.38) | 0.46 |
Debt/Assets |
34.81% | 43.85% | 35.03% | 35.65% | 6.98% | 8.01% | 27.79% | 27.12% | 25.15% | 14.63% |
Debt/Equity |
0.72 | 1.03 | 0.66 | 0.67 | 0.08 | 0.09 | 0.44 | 0.41 | 0.37 | 0.19 |
Asset Turnover |
0.79 | 0.65 | 0.60 | 0.22 | 0.11 | 0.11 | 0.35 | 0.36 | 0.41 | 0.46 |
Operating CF/Net income |
(1.47) | (0.29) | (1.59) | (0.01) | (0.45) | 0.11 | (0.30) | 0.05 | 0.32 | 0.70 |
Capex/Depreciation |
(0.35) | (0.11) | (0.45) | (0.02) | (0.42) | (0.39) | (0.26) | (0.13) | (0.21) | (0.29) |
Interest Coverage |
(13.34) | (42.89) | (11.15) | (622.18) | (3.27) | (8.45) | (2.74) | (2.71) | (4.31) | (24.21) |
| (13.93%) | (52.46%) | (9.51%) | (148.85%) | (2.69%) | (5.74%) | (9.75%) | (12.35%) | (27.04%) | (36.25%) | |
| (6.28%) | (25.32%) | (5.04%) | (123.73%) | (2.42%) | (5.01%) | (6.31%) | (8.25%) | (18.93%) | (27.83%) | |
ROIC |
(10.27%) | (36.78%) | (5.67%) | (290.36%) | (1.01%) | (1.92%) | (5.34%) | (4.67%) | (7.32%) | (18.70%) |
Return on Tangible Assets |
(27.02%) | (133.17%) | (20.03%) | (1,445.06%) | (46.52%) | (64.21%) | (19.46%) | (20.21%) | (85.51%) | (107.37%) |
Average Days of Receivables |
27.82 | 30.42 | 30.49 | 31.93 | 30.34 | 56.48 | 37.57 | 38.05 | 42.39 | 40.92 |
Research and Development Expense of Revenue |
10.99% | 11.96% | 13.39% | 13.86% | 15.34% | 15.08% | 11.68% | 13.01% | 14.77% | 17.71% |
Selling, General and Administrative Expense of Revenue |
50.58% | 52.39% | 52.54% | 54.04% | 54.38% | 81.07% | 61.28% | 62.50% | 75.20% | 88.94% |
Intangible Assets out of Total Assets |
0.55 | 0.49 | 0.63 | 0.67 | 0.93 | 0.94 | 0.61 | 0.64 | 0.80 | 0.70 |
Share Based Compensation of Revenue |
3.18% | 5.68% | 7.74% | 9.05% | 14.89% | 43.47% | 12.06% | 10.47% | 13.12% | 6.27% |
Graham Net Nets |
(0.29) | (0.23) | (0.16) | (0.20) | (0.03) | (0.04) | 0.00 | 0.01 | (0.05) | 0.01 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(16.29%) | (64.69%) | (6.11%) | (375.29%) | (3.02%) | (2.68%) | (1.65%) | (2.99%) | (5.22%) | (10.55%) |
Free Cash Flow Yield |
11.13% | 3.86% | 1.00% | (3.83%) | 0.52% | (0.56%) | 0.19% | (0.37%) | (2.14%) | (8.10%) |
Revenue per Share |
14.36 | 15.07 | 15.81 | 14.91 | 12.95 | 12.09 | 7.70 | 6.35 | 4.21 | 2.91 |
Operating CF per Share |
1.67 | 1.72 | 2.13 | 1.17 | 1.24 | (0.59) | 0.42 | (0.07) | (0.62) | (1.23) |
Capex per Share |
(0.89) | (0.73) | (0.95) | (2.04) | (0.76) | (0.53) | (0.25) | (0.11) | (0.15) | (0.11) |
Free Cash Flow per Share |
0.78 | 0.99 | 1.18 | (0.87) | 0.48 | (1.12) | 0.16 | (0.18) | (0.77) | (1.34) |
Cash per Share |
4.43 | 7.61 | 6.83 | 5.69 | 5.71 | 8.69 | 7.20 | 7.27 | 2.21 | 1.55 |
Shareholders Equity per Share |
7.86 | 8.74 | 14.13 | 14.29 | 102.24 | 175.49 | 14.11 | 15.39 | 10.08 | 5.45 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.86 | 8.74 | 14.13 | 14.29 | 102.24 | 175.49 | 14.11 | 15.39 | 10.08 | 5.45 |
Free Cash Flow |
137.33 | 169.63 | 193.67 | (139.76) | 74.66 | (101.57) | 11.58 | (12.13) | (42.84) | (56.59) |
Working Capital |
714.39 | 722.37 | 1,068.43 | 915.62 | 894.43 | 726.96 | 497.82 | 470.30 | 115.91 | 61.64 |
Capital Expenditures |
(157.02) | (124.05) | (156.35) | (329.05) | (119.33) | (48.06) | (18.29) | (7.27) | (8.40) | (4.72) |
Net Current Asset Value |
(353.46) | (361.54) | (577.25) | (722.22) | (463.41) | (811.87) | (0.80) | 16.98 | (109.25) | 9.92 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.06 | 0.05 | 0.06 | 0.14 | 0.06 | 0.04 | 0.03 | 0.02 | 0.04 | 0.04 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
16.62 | 39.77 | 10.89 | 461.21 | 10.31 | 4.32 | 6.84 | 5.43 | 4.42 | 2.17 |
Cash ROIC |
4.34% | 3.92% | 3.88% | (2.93%) | 0.41% | (0.56%) | 0.59% | (0.64%) | (4.82%) | (16.59%) |
Accounts Receivable Turnover |
12.43 | 11.91 | 12.16 | 12.68 | 12.02 | 9.67 | 11.01 | 11.83 | 11.41 | 9.50 |
Accounts Payable Turnover |
19.03 | 19.57 | 16.64 | 15.67 | 13.94 | 14.18 | 21.90 | 22.09 | 20.14 | 14.37 |
Inventory Turnover |
20.21 | 22.21 | 17.71 | 11.50 | 10.04 | 6.06 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
22.69 | 16.10 | 20.96 | 23.40 | 26.53 | 42.99 | 17.96 | 22.03 | 23.01 | 25.53 |
Days of Inventory on Hand |
18.07 | 18.53 | 14.17 | 27.64 | 41.02 | 52.76 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
203.49 | 215.78 | 213.99 | 189.76 | 169.12 | 113.11 | 50.26 | 35.33 | 20.45 | 12.97 |
Average Payables |
40.55 | 38.38 | 45.66 | 47.47 | 46.64 | 27.55 | 8.42 | 5.83 | 3.06 | 2.22 |
Average Inventory |
38.17 | 33.83 | 42.93 | 64.71 | 64.79 | 64.50 | — | — | — | — |
Average Assets |
3,187.41 | 3,954.45 | 4,368.86 | 11,039.98 | 17,744.95 | 9,679.05 | 1,565.85 | 1,176.63 | 564.03 | 266.70 |
Average Common Equity |
1,438.39 | 1,908.58 | 2,316.91 | 9,176.75 | 15,964.78 | 8,448.91 | 1,013.57 | 786.01 | 394.89 | 204.72 |
Columns are period end dates